Abstract
1. The pharmacokinetics of pholcodine after two single doses and after chronic administration were studied in healthy human volunteers. 2. Six subjects received single oral doses of 20 and 60 mg of pholcodine according to a balanced cross-over design with an interval of 3 weeks between the two treatments. Blood and saliva samples and all urine were collected over 168 h after each dosage administration. Subsequently, the same subjects received 20 mg pholcodine 8 hourly orally for 10 days. Blood and saliva samples and all urine were collected during an 8 h dosing interval after the last dose on day 11. 3. Plasma, saliva and urine concentrations of pholcodine were determined by a high performance liquid chromatographic assay. 4. After the single doses, pholcodine was absorbed rapidly (tmax = 1.6 +/- 1.2 h) and eliminated slowly with a mean half-life of 50.1 +/- 4.1 h. The renal clearance of pholcodine was 137 +/- 34 ml min-1 and was inversely correlated with urine pH (r = 0.60) but not with urine flow rate. 26.2 +/- 3.3% of the dose was excreted as unchanged pholcodine after both doses. The concentration of pholcodine in saliva was 3.6 times higher than in plasma. 5. After chronic administration, the pharmacokinetics of pholcodine were not statistically different from the single dose parameters. 6. Pholcodine did not appear to undergo conjugation. The plasma protein binding was 23.5%. Morphine, in unconjugated or conjugated form, was not detected in the urine of any subject after pholcodine administration.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aylward M., Maddock J., Davies D. E., Protheroe D. A., Leideman T. Dextromethorphan and codeine: comparison of plasma kinetics and antitussive effects. Eur J Respir Dis. 1984 May;65(4):283–291. [PubMed] [Google Scholar]
- Butz R. F., Jones E. C., Welch R. M., Findlay J. W. Pharmacokinetics and O-dealkylation of morphine-3-alkyl ethers in the rat. A radioimmunoassay study. Drug Metab Dispos. 1983 Sep-Oct;11(5):481–488. [PubMed] [Google Scholar]
- Chen Z. R., Siebert D. M., Somogyi A. A., Bochner F. Determination of pholcodine in biological fluids by high-performance liquid chromatography with fluorescence detection. J Chromatogr. 1988 Jan 22;424(1):170–176. doi: 10.1016/s0378-4347(00)81090-7. [DOI] [PubMed] [Google Scholar]
- Chiou W. L. Rapid compartment- and model-independent estimation of times required to attain various fractions of steady-state plasma level during multiple dosing of drugs obeying superposition principle and having various absorption or infusion kinetics. J Pharm Sci. 1979 Dec;68(12):1546–1547. doi: 10.1002/jps.2600681222. [DOI] [PubMed] [Google Scholar]
- Eddy N. B., Friebel H., Hahn K. J., Halbach H. Codeine and its alternates for pain and cough relief . 4. Potential alternates for cough relief. Bull World Health Organ. 1969;40(5):639–719. [PMC free article] [PubMed] [Google Scholar]
- Findlay J. W., Fowle A. S., Butz R. F., Jones E. C., Weatherley B. C., Welch R. M., Posner J. Comparative disposition of codeine and pholcodine in man after single oral doses. Br J Clin Pharmacol. 1986 Jul;22(1):61–71. doi: 10.1111/j.1365-2125.1986.tb02881.x. [DOI] [PMC free article] [PubMed] [Google Scholar]